NL1026989A1 - Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors. - Google Patents

Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors.

Info

Publication number
NL1026989A1
NL1026989A1 NL1026989A NL1026989A NL1026989A1 NL 1026989 A1 NL1026989 A1 NL 1026989A1 NL 1026989 A NL1026989 A NL 1026989A NL 1026989 A NL1026989 A NL 1026989A NL 1026989 A1 NL1026989 A1 NL 1026989A1
Authority
NL
Netherlands
Prior art keywords
reuptake inhibitors
combination
norepinephrine
serotonin
serotonin reuptake
Prior art date
Application number
NL1026989A
Other languages
Dutch (nl)
Other versions
NL1026989C2 (en
Inventor
Megan Ann Gibbs
Earl Laux Giller Jr
Gerard Joseph Marek
Robert Clyde Marshall
Tatiana Stanislavovna Ramey
Erik Ho Fong Wong
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/769,018 external-priority patent/US20050014848A1/en
Priority claimed from US10/860,721 external-priority patent/US20050009927A1/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NL1026989A1 publication Critical patent/NL1026989A1/en
Application granted granted Critical
Publication of NL1026989C2 publication Critical patent/NL1026989C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL1026989A 2003-09-09 2004-09-08 Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors. NL1026989C2 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US50127503P 2003-09-09 2003-09-09
US50127503 2003-09-09
US53889804P 2004-01-23 2004-01-23
US53889804 2004-01-23
US54069604P 2004-01-30 2004-01-30
US54069604 2004-01-30
US76901804 2004-01-30
US10/769,018 US20050014848A1 (en) 2002-01-23 2004-01-30 Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors
US10/860,721 US20050009927A1 (en) 2002-01-23 2004-06-03 Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors
US86072104 2004-06-03

Publications (2)

Publication Number Publication Date
NL1026989A1 true NL1026989A1 (en) 2005-03-10
NL1026989C2 NL1026989C2 (en) 2006-01-10

Family

ID=34280166

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1026989A NL1026989C2 (en) 2003-09-09 2004-09-08 Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors.

Country Status (7)

Country Link
EP (1) EP1667686A1 (en)
BR (1) BRPI0413726A (en)
CA (1) CA2542339A1 (en)
MX (1) MXPA06002778A (en)
NL (1) NL1026989C2 (en)
TW (1) TW200526197A (en)
WO (1) WO2005023265A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042806A1 (en) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd COMBINATION OF CARBOSTIRILE DERIVATIVES AND INHIBITORS OF SEROTONINE REABSORTION FOR THE TREATMENT OF ANIMO DISORDERS
PT1575590E (en) 2002-12-27 2007-12-06 Otsuka Pharma Co Ltd Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
KR20070029740A (en) * 2004-06-09 2007-03-14 화이자 인코포레이티드 Use of reboxetine for the treatment of pain
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232805A1 (en) * 2002-04-24 2003-12-18 Cypress Bioscience, Inc. Prevention and treatment of functional somatic disorders, including stress-related disorders

Also Published As

Publication number Publication date
EP1667686A1 (en) 2006-06-14
CA2542339A1 (en) 2005-03-17
NL1026989C2 (en) 2006-01-10
TW200526197A (en) 2005-08-16
WO2005023265A1 (en) 2005-03-17
MXPA06002778A (en) 2006-06-14
BRPI0413726A (en) 2006-11-07

Similar Documents

Publication Publication Date Title
IS8136A (en) N-pyrrolidin-3-yl-amide derivatives that inhibit serotonin and norepinephrine reuptake
CY2014022I1 (en) PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS
NL1030486A1 (en) Dibenzylamine compounds and derivatives.
NO20034307D0 (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
NO20044345L (en) NE and 5-HT reuptake inhibitors for the treatment of visceral pain syndromes
IL188614A0 (en) Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof
DE602004018837D1 (en) PTIDASE-IV INHIBITORS
EP1746985A4 (en) Method for augmenting the effects of serotonin reuptake inhibitors
DK1643985T3 (en) The combination of a serotonin reuptake inhibitor and agomelatine
NO20043124L (en) Aminoindane derivatives such as serotonin and norepinephrine uptake inhibitors
ATE449633T1 (en) COMBINATIONS OF ALPHA-2-DELTA LIGANDS AND SEROTONIN / NORADRENALINE REUPPOST INHIBITORS
NO20034525L (en) Phenyl heterocyclyl ether derivatives with serotonin reuptake inhibitors
NO20042904L (en) Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
NL1026989A1 (en) Combination of serotonin reuptake inhibitors and norepinephrine reuptake inhibitors.
PL1710240T3 (en) Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
IS8326A (en) The mixture of serotonin reuptake inhibitor and loxapine
HK1095135A1 (en) Morpholine derivatives as norepinephrine reuptake inhibitors
IS2815B (en) 2- (1H-indolylsulfanyl) -benzylamine derivatives as selective serotonin reuptake inhibitors (SSRIs).
IS8102A (en) Composition of ras-farnesyltransferase inhibitors, cyclodextrin and ethanol
ITMO20030214A1 (en) MEANS OF CONTAINERS.
ES1055479Y (en) HYGIENIC SEAL FOR REFRESH AND SIMILAR CANS.
IL184096A0 (en) Antidepressant medicament comprising idazoxan and a selective serotonin reuptake inhibitor
ITRM20030053A1 (en) ASSOCIATION OF ANTIABETIC DRUGS.
SE0300014D0 (en) NEW FABP4 INHIBITORS
UA7666S (en) BOTTLE OF BRAND

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20050907

PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20090401